Why the study?
Delivery of the placenta is the only cure for preeclampsia, making prevention options necessary, but little consensus exists regarding their effectiveness.
Do pharmacological interventions and dietary supplementations prevent preeclampsia in pregnant women?
Do pharmacological interventions and dietary supplementations prevent preeclampsia in pregnant women?
Aspirin and isosorbide mononitrate may be effective in preventing preeclampsia, whereas current evidence does not support the use of dietary supplementations for this purpose.
May support targeted pharmacological prevention in high-risk pregnancies; extends synthesis of evidence amid prior lack of consensus.
Background: Preeclampsia is a disorder of pregnancy that increases risk for long-term health consequences for both mother and child, and if left untreated is one of the main causes of maternal and fetal mortality. However, delivery of the placenta is the only cure, making prevention options for this condition needed but little consensus exist on their effectiveness. Thus, we conducted a systematic review on the effectiveness of pharmacological and non-pharmacological interventions to prevent preeclampsia. Methods: We used MEDLINE and ProQuest to conduct a systematic search for peer-review publications on prevention of preeclampsia. We selected studies conducted in human and published in English from 2010 through 2020 on: i) types of interventions; ii) quality of studies and limitations. We selected 22 articles to be reviewed. Results: Eleven types of pharmacological and non-pharmacological interventions were identified. Nitric Oxide-donors with Isosorbide Mononitrate (IMN), and aspirin have been shown to be effective, while selenium, calcium, vitamin D, DHA-rich fish oil-concentrate, copper, phytonutrient, Nitric Oxide-donors with Penthaerythrityl Tetranitrate (PETN), folic acid, vitamins C and E and magnesium have not been proved effective to prevent preeclampsia. Although all studies presented good quality of evidence, they had several limitations, the most common limitations are lack of initial therapy, lack of dosage, and inadequate sample size to detect small effect. Conclusion: Despite the growing evidence of treatments to prevent preeclampsia, their effect is not large. More research is needed in the field before prevention treatments are prescribed in clinical settings. Keywords: prevention; pharmacological; non-pharmacological; Systematic Literature Review; preeclampsia.
No takes yet. Share an insight, caveat, or question.
Fatimatasari et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: